MEREDITH OLIVER: Open Payments
NPI 1770082463 · MONROE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,027 in 137 payments from 21 companies in 2025. Trend: 2023 $2,504 · 2024 $3,087 · 2025 $3,027
Food & beverage: $2,943Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $640 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $460 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $397 |
| Janssen Biotech, Inc. | 11 | $383 |
| PFIZER INC. | 12 | $242 |
| Madrigal Pharmaceuticals | 5 | $109 |
| Ardelyx, Inc. | 5 | $99 |
| Gilead Sciences, Inc. | 5 | $98 |
| Lilly USA, LLC | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
Products named: RINVOQ, TREMFYA, ENTYVIO, XIFAXAN, VELSIPITY, DUPIXENT, RELISTOR, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
